Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Profound Medical Corp.

Get SEC filing alerts via email and in your feed for Profound Medical Corp.

PROF

Profound Medical Corp.

About Profound Medical Corp.

Profound Medical develops MRI-guided, incision-free therapeutic systems for minimally invasive ablation of diseased tissue, primarily targeting prostate conditions and uterine fibroids. Its flagship products, TULSA-PRO and Sonalleve, utilize real-time MRI, focused ultrasound, and thermal feedback to deliver precise, customizable treatments. Serving global markets, the company offers solutions that aim to improve clinical outcomes, reduce side effects, and enable outpatient procedures in urology and gynecology.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Profound Medical Corp.

1
1
Profound Medical Corp. Profound Medical Corp. Reports 104% Revenue Growth to $5.34 Million in Latest Quarter

Via official filing (AI summary) | 29 days ago | 0 comments

2
1
Profound Medical Corp. Profound Medical Reports 51% Revenue Growth to $16.1 Million for Fiscal Year 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
Profound Medical Corp. Profound Medical Reports 87% Revenue Growth in Q3 2025 Amid Increased Losses

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Profound Medical Corp. Profound Medical Reports Q2 2025 Revenue of $2.2M, Net Loss of $15.7M

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Profound Medical Corp. Profound Medical Reports 82% Revenue Increase to $2.621 Million in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Profound Medical Corp. Profound Medical Corp. Reports 48% Revenue Increase to $10.68 Million for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments